Multiple Myleoma

Oncology·MeSH: Lymphoma, Non-Hodgkin

Prevalence

30.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Multiple Myleoma?

There are 1 clinical trial targeting Multiple Myleoma tracked by BioSniper.

What is the prevalence of Multiple Myleoma?

The estimated prevalence of Multiple Myleoma is approximately 30.0 per 100,000 population.

Deep-dive into Multiple Myleoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Multiple Myleoma — Drugs in Development & Clinical Trials | BioSniper